The In Vivo Antidiabetic Activity of Nigella sativa Is Mediated through Activation of the AMPK Pathway and Increased Muscle Glut4 Content

Table 2

Area-under-the-curve (glyceamic (mmol/L)*time (min)) for OGTT before and after 4-week treatment.

Time (week)	Treatment
	N. sativa	Metformin	Diabetic control	Normal control
0	1648 ± 107	1685 ± 84	1666 ± 82	956 ± 61^§
4	1163 ± 81^*§	819 ± 54^*§	1514 ± 83	941 ± 41^§

*Significantly different from week 0; 𝑃<.05; ^§Significantly different from Diabetic controls; 𝑃<.05.